|
Volumn 2, Issue 4, 2007, Pages 263-264
|
Pure red cell aplasia and thymoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
ANDROGEN;
ANTIINFECTIVE AGENT;
CYCLOSPORIN;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
PREDNISONE;
RITUXIMAB;
THYMOCYTE ANTIBODY;
AUTOIMMUNE DISEASE;
BONE MARROW BIOPSY;
EDITORIAL;
ERYTHROPOIESIS;
HUMAN;
HYPOGAMMAGLOBULINEMIA;
MYASTHENIA GRAVIS;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
PURE RED CELL ANEMIA;
SPLENECTOMY;
THROMBOCYTOPENIC PURPURA;
THYMOMA;
FEMALE;
FOLLOW UP;
HOSPITALIZATION;
MALE;
METHODOLOGY;
NOTE;
PARANEOPLASTIC SYNDROME;
RISK ASSESSMENT;
THYMECTOMY;
FEMALE;
FOLLOW-UP STUDIES;
GAMMA-GLOBULINS;
HUMANS;
MALE;
PARANEOPLASTIC SYNDROMES;
RED-CELL APLASIA, PURE;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
THYMECTOMY;
THYMOMA;
THYMUS NEOPLASMS;
|
EID: 34247874703
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/01.JTO.0000263705.23579.ee Document Type: Editorial |
Times cited : (13)
|
References (10)
|